Idiopathic hypersomnia

Sleepiness: Causes, Consequences and Treatment

Volumn , Issue , 2011, Pages 126-135

  Billiard, Michel ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869771015     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511762697.014     Document Type: Chapter

References (60)

1. Westphal C. Eigentümliche mit Einschlafen verbundene Anfälle. Arch Gen Psychiatr Nervenkr, 1877; 7:631–65.
2. Gelineau J. De la narcolepsie. Gaz des Hôp (Paris), 1880; 55, 626–28; 635–37.
3. Kleine W. Periodische Schlafsucht. Mschr Psychiat Neurol, 1925; 57:285–320.
4. Roth B. Narcolepsy and hypersomnia: review and classification of 642 personally observed cases. Schweiz Arch Neurol Neurochir Psychiat, 1976; 119:31–41.
5. Billiard M. Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the international classification of sleep disorders, 2nd edition. Sleep Med Rev, 2007; 11:377–88.
6. Roth B. Spankova opilost a spánkova óbrna. Ceskoslovenska Neurol, 1956; 19:48–58.
7. Roth B. Narkolepsie a Hypersomnie S. Hlediska Fysiologie Spanku. Praha: Statni Zdravonické Nakladatelstvi, 1957.
8. Roth B, Nevsimalova S, Rechtschaffen A. Hypersomnia with sleep drunkenness. Arch Gen Psychiat, 1972; 26:456–62.
9. Association of Sleep Disorders Centers. Diagnostic Classification of Sleep and Arousal Disorders, First edition, prepared by the Sleep Disorders Classification Committee, HP. Roffwarg, Chairman. Sleep, 1979; 2:1–137.
10. ICSD. International Classification of Sleep Disorders: Diagnostic and Coding Manual. Diagnostic Classification Steering Committee. Thorpy M J, Chairman. Rochester, MN: American Sleep Disorders Association, 1990.
11. Bassetti C, Aldrich MS. Idiopathic hypersomnia. A series of 42 patients. Brain1997; 120:1423–35.
12. Billiard M, Merle C, Carlander B, et al.Idiopathic hypersomnia. Psychiatr Clin Neurosci1998; 52:125–29.
13. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Diagnostic and Coding Manual(2nd Ed). Westchester, IL: American Academy of Sleep Medicine, 2005.
14. Nevsimalova-Bruhova S. On the problem of heredity in hypersomnia, narcolepsy and dissociated sleep disturbances. Acta Univ Carol Med (Praha), 1973; 18:109–60.
15. Van Den Hoed J, Kraemer H, Guilleminault C, et al.Disorders of excessive daytime somnolence: polygraphic and clinical data for 100 patients. Sleep, 1981; 4:23–37.
16. Coleman RM, Roffwarg H P, Kennedy S J, et al.Sleep–wake disorders based on a polysomnographic diagnosis. A national cooperative study. JAMA, 1982; 247:997–1003.
17. Baker T L, Guilleminault C, Nino-Murcia G, et al.Comparative polysomnographic study of narcolepsy and idiopathic central nervous system hypersomnia. Sleep, 1986; 9:232–42.
18. Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology, 1996; 46:393–401.
19. Bruck D, Parkes J D. A comparison of idiopathic hypersomnia and narcolepsy using self report measures and sleep diary data. J Neurol Neurosurg Psychiatry, 1996; 60:576–78.
20. Vignatelli L, d’Alessandro R, Mosconi P, et al.Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. Sleep Med, 2004; 5:467–75.
21. Heier M S, Evsiukova T, Vilming S, et al.CSF hypocretin-1 levels and clinal profiles in narcolepsy and idiopathic CNS hypersomnia in Norway. Sleep, 2007; 30:969–73.
22. Kanbayashi T, Inoue Y, Chgiba S, et al.CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res, 2002; 11:91–93.
23. Vernet C, Arnulf I. Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep, 2009; 32:753–59.
24. Vernet C, Arnulf I. Narcolepsy with long sleep time: a specific entity? Sleep, 2009; 32:1229–35.
25. Dauvilliers Y, Paquereau J, Bastuji H, et al.Psychological health in central hypersomnias: the French Harmony Study. J Neurol Neurosurg Psychiatry, 2009; 80:636–41.
26. Anderson K N, Pilsworth S, Sharples L D, et al.Idiopathic hypersomnia: a study of 77 cases. Sleep, 2007; 30:1274–81.
27. Sangal R B, Sangal JM. P300 latency: abnormal in sleep apnea with somnolence and idiopathic hypersomnia, but normal in narcolepsy. Clin Electroencephalogr, 1995; 26:146–53.
28. Mignot E, Lammers G J, Ripley B, et al.The role of cerebrospinal fluid hypocretin in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol, 2002; 59:1553–62.
29. Bassetti C, Gugger M, Bischof M, et al.The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin). Sleep Med, 2003; 4:7–12.
30. Dauvilliers Y, Baumann C R, Carlander B, et al.CSF hypocretin-1 levels in narcolepsy, Kleine–Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry, 2003; 74:1667–73.
31. Broughton R, Nevsimalova S, Roth B. The socioeconomic effects (including work, education, recreation and accidents) of idiopathic hypersomnia. Sleep Res, 1978; 7:217.
32. Billiard M. Narcolepsy and idiopathic hypersomnia. In: Léger D, Pandi-Perumal S R, Eds. Sleep Disordes: their Impact on Public Health. Abingdon: Informa Healthcare, 2007:225–34.
33. Sasai T, Inoue Y, Komada Y, et al.Comparison of clinical characteristics among narcolepsy with and without cataplexy and idiopathic hypersomnia without long sleep time focusing on HLA-DRB1(7)1501/DQB1(7)0602 finding. Sleep Med, 2009; 10:961–66.
34. Billiard M, Pasquié-Magnetto V, Heckman M, et al.Family studies in narcolepsy. Sleep, 1994; 17:S54–59.
35. Mignot E. Genetic and familial aspects of narcolepsy. Neurology, 1998; 50(Suppl 1):S16–22.
36. Ozaki A, Inoue Y, Nakajima T et al.Health-related quality of life among drug-naïve patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time. J Clin Sleep Med, 2008; 4:572–78.
37. Shinno H, Inami Y, Inagaki T, et al.Successful treatment with levothyroxine for idiopathic hypersomnia patients with subclinical hypothyroidism. Gen Hosp Psychiat, 2009; 31: 190–93.
38. Nofzinger E A, Thase ME, Reynolds C F III, et al.Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test. Am J Psychiatry, 1991; 148:1177–81.
39. Guilleminault C, Faull K F, Miles L, et al.Post-traumatic excessive daytime sleepiness. A review of 20 patients. Neurology, 1980; 33:1584–89.
40. Rao V, Rollings P. Sleep disturbances following traumatic brain injury. Curr Treat Opt Neurol, 2002; 4:77–82.
41. Guilleminault C, Mondini S. Infectious mononucleosis and excessive daytime sleepiness. A long-term follow-up study. Arch Inter Med, 1986; 146:1333–35.
42. Fukuda D, Strauss S E, Hickie I, et al.The chronic fatigue syndrome: comprehensive approach to its definition and study. Ann Int Med, 1994; 121:953–59.
43. Roehrs T, Zorick F, Sicklesteel J, et al.Excessive daytime sleepiness associated with insufficient sleep. Sleep, 1983; 6:319–25.
44. Billiard M, Dauvilliers Y. Idiopathic hypersomnia. Sleep Med Rev, 2001; 5:351–60.
45. Nevsimalova-Bruhova S, Roth B. Heredofamilial aspects of narcolepsy and hypersomnia. Schweiz Arch Neurol Neurochir Psychiat, 1972; 110:45–54.
46. Roth B. Idiopathic hypersomnia. In: Roth B, Ed. Narcolepsy and Hypersomnia. Basel: Karger, 1980:207–27.
47. Petitjean F, Jouvet M. Hypersomnie et augmentation de l’acide 5-hydroxy-indoleacétique cérébral par lésion isthmique chez le chat. C R séances Soc Biol (Lyon), 1970; 164:2288–93.
48. Montplaisir J, de Champlain J, Young S N, et al.Narcolepsy and idiopathic hypersomnia: biogenic amines and related compounds in CSF. Neurology, 1982; 32:1299–302.
49. Faull K F, Guilleminault C, Berger P A, et al.Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia. Ann Neurol, 1983; 13:258–63.
50. Faull K F, Thiemann S, King R J, et al.Monoamine interactions in narcolepsy and hypersomnia: a preliminary report. Sleep, 1986; 9:246–49.
51. Kanbayashi T, Kodama T, Kondo H, et al.CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep, 2009; 32:175–80.
52. Bassetti C L, Khatami R, Poryazova R, et al.Idiopathic hypersomnia: a dopaminergic disorder. Sleep, 2009; 32:A248–49 (abstract suppl).
53. Mühlethaler M. Potential mechanisms of the wake-promoting action of hypocretin/orexin. In Bassetti C L, Billiard M, Mignot E, Eds. Narcolepsy and Hypersomnia. New York, NY: Informa Healthcare, 2007:347–54.
54. Nishino S, Ripley B, Overeem S, et al.Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 2000; 355:39–40.
55. Nishino S, Ripley B, Overeem S, et al.Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol, 2001; 50:381–88.
56. Billiard M, Rondouin G, Espa F, et al.Pathophysiology of idiopathic hypersomnia. Rev Neurol (Paris), 2001; 157:5S101–06.
57. Boeve A, Culebras A, Moore J T, et al.Relationship between sleep spindles and hypersomnia. Sleep, 1994; 17:449–55.
58. Nevsimalova S, Blazejova K, Illnerova H, et al.A contribution to pathophysiology of idiopathic hypersomnia. In: Ambler Z, Nevsimalova S, Kadanza Z, Rossini P M, Eds. Clinical Neurophysiology at the Beginning of the 21st Century(supplement to Clinical Neurophysiology), 2000; 53:366–70.
59. Bastuji H, Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuro Psychopharmacol and Biol. Psychiat, 1988; 12:695–700.
60. Montplaisir J, Fantini L. Idiopathic hypersomnia: a diagnostic dilemma. Sleep Med Rev, 2001; 5:361–62.